A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)
Clinical trial NCT03448692 · TERMINATED
Trial details
- NCT number
- NCT03448692
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2023-02-14
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.